Gut,
Journal Year:
2023,
Volume and Issue:
72(10), P. 1838 - 1847
Published: Feb. 14, 2023
Ulcerative
colitis
(UC)
is
a
chronic
inflammatory
disorder
of
unknown
aetiology.
Gut
virome
dysbiosis
fundamental
in
UC
progression,
although
its
role
the
early
phases
disease
far
from
fully
understood.
Therefore,
we
sought
to
investigate
virome-associated
protein
encoded
by
Viruses,
Journal Year:
2021,
Volume and Issue:
13(8), P. 1463 - 1463
Published: July 27, 2021
Hepatitis
B
virus
(HBV)
remains
a
major
medical
problem
affecting
at
least
257
million
chronically
infected
patients
who
are
risk
of
developing
serious,
frequently
fatal
liver
diseases.
HBV
is
small,
partially
double-stranded
DNA
that
goes
through
an
intricate
replication
cycle
in
its
native
cellular
environment:
human
hepatocytes.
A
critical
step
the
viral
life-cycle
conversion
relaxed
circular
(rcDNA)
into
covalently
closed
(cccDNA),
latter
being
template
for
gene
transcription.
For
this
conversion,
relies
on
multiple
host
factors,
as
enzymes
capable
catalyzing
relevant
reactions
not
encoded
genome.
Combinations
genetic
and
biochemical
approaches
have
produced
findings
provide
more
holistic
picture
complex
mechanism
cccDNA
formation.
Here,
we
review
some
these
studies
helped
to
comprehensive
rcDNA
conversion.
Mechanistic
insights
persistence
hold
key
devising
new
therapies
will
lead
only
suppression
but
cure.
Virulence,
Journal Year:
2022,
Volume and Issue:
13(1), P. 258 - 296
Published: Jan. 31, 2022
Hepatitis
B
virus
(HBV)
is
a
hepatotropic
and
an
important
human
pathogen.
There
are
estimated
296
million
people
in
the
world
that
chronically
infected
by
this
virus,
many
of
them
will
develop
severe
liver
diseases
including
hepatitis,
cirrhosis
hepatocellular
carcinoma
(HCC).
HBV
small
DNA
replicates
via
reverse
transcription
pathway.
In
review,
we
summarize
molecular
pathways
govern
replication
its
interactions
with
host
cells.
We
also
discuss
viral
non-viral
factors
associated
HBV-induced
carcinogenesis
pathogenesis,
as
well
role
immune
responses
persistence
pathogenesis.
Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
13
Published: Aug. 12, 2022
Infectious
diseases,
caused
by
pathogenic
microorganisms,
are
capable
of
affecting
crises.
In
addition
to
persistent
infectious
diseases
such
as
malaria
and
dengue
fever,
the
vicious
outbreaks
Neocon,
Ebola
SARS-CoV-2
in
recent
years
have
prompted
search
for
more
efficient
convenient
means
better
diagnosis
treatment.
Antibodies
attracted
a
lot
attention
due
their
good
structural
characteristics
applications.
Nanobodies
smallest
functional
single-domain
antibodies
known
be
able
bind
stably
antigens,
with
advantages
high
stability,
hydrophilicity,
easy
expression
modification.
They
can
directly
target
antigen
epitopes
or
constructed
multivalent
nanobodies
nanobody
fusion
proteins
exert
therapeutic
effects.
This
paper
focuses
on
construction
methods
potential
functions
nanobodies,
outlines
progress
research,
highlights
various
applications
human
diseases.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
148, P. 112743 - 112743
Published: Feb. 25, 2022
Viral
infections
are
a
common
cause
of
morbidity
worldwide.
The
emergence
Coronavirus
Disease
2019
(COVID-19)
has
led
to
more
attention
viral
and
finding
novel
therapeutics.
CRISPR-Cas9
system
been
recently
proposed
as
potential
therapeutic
tool
for
the
treatment
diseases.
Here,
we
review
research
progress
in
use
CRISPR-Cas
technology
treating
infections,
well
strategies
improving
delivery
this
gene-editing
vivo.
Key
challenges
that
hinder
widespread
clinical
application
also
discussed,
several
possible
directions
future
proposed.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(5), P. 4964 - 4964
Published: March 4, 2023
The
hepatitis
B
virus
(HBV)
counts
as
a
major
global
health
problem,
it
presents
significant
causative
factor
for
liver-related
morbidity
and
mortality.
development
of
hepatocellular
carcinomas
(HCC)
characteristic
persistent,
chronic
infection
could
be
caused,
among
others,
by
the
pleiotropic
function
viral
regulatory
protein
HBx.
latter
is
known
to
modulate
an
onset
cellular
signaling
processes
with
emerging
influence
in
liver
pathogenesis.
However,
flexible
multifunctional
nature
HBx
impedes
fundamental
understanding
related
mechanisms
associated
diseases,
has
even
led
partial
controversial
results
past.
Based
on
distribution
HBx—nuclear-,
cytoplasmic-
or
mitochondria-associated—this
review
encompasses
current
knowledge
previous
investigations
context
pathways
HBV-associated
In
addition,
particular
focus
set
clinical
relevance
potential
novel
therapeutic
applications
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2023,
Volume and Issue:
13
Published: March 15, 2023
Hepatitis
B
virus
infections
have
always
been
associated
with
high
levels
of
mortality.
In
2019,
hepatitis
(HBV)-related
diseases
resulted
in
approximately
555,000
deaths
globally.
view
its
lethality,
the
treatment
HBV
has
presented
a
huge
challenge.
The
World
Health
Organization
(WHO)
came
up
ambitious
targets
for
elimination
as
major
public
health
threat
by
2030.
To
accomplish
this
goal,
one
WHO’s
strategies
is
to
develop
curative
treatments
infections.
Current
clinical
setting
included
1
year
pegylated
interferon
alpha
(PEG-IFNα)
and
long-term
nucleoside
analogues
(NAs).
Although
both
demonstrated
outstanding
antiviral
effects,
it
difficult
cure
HBV.
reason
that
covalently
closed
circular
DNA
(cccDNA),
integrated
DNA,
viral
burden,
impaired
host
immune
responses
all
hinder
development
overcome
these
problems,
there
are
trials
on
number
molecules
being
carried
out,
-showing
promising
results
so
far.
review,
we
summarize
functions
mechanisms
action
various
synthetic
molecules,
natural
products,
traditional
Chinese
herbal
medicines,
clustered
regularly
interspaced
short
palindromic
repeats
their
proteins
(CRISPR/Cas)-based
systems,
zinc
finger
nucleases
(ZFNs),
transcription
activator-like
effector
(TALENs),
which
could
destroy
stability
life
cycle.
addition,
discuss
modulators,
can
enhance
or
activate
system,
well
some
representative
products
anti-HBV
effects.
Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Jan. 12, 2024
Abstract
Eukaryotic
five-methylcytosine
(m
5
C)
is
an
important
regulator
of
viral
RNA
splicing,
stability,
and
translation.
However,
its
role
in
HBV
replication
remains
largely
unknown.
In
this
study,
functional
m
C
sites
are
identified
hepatitis
B
virus
(HBV)
mRNA.
The
modification
at
nt
1291
not
only
indispensable
for
Aly/REF
export
factor
(ALYREF)
recognition
to
promote
mRNA
HBx
translation
but
also
the
inhibition
RIG-I
binding
suppress
interferon-β
(IFN-β)
production.
Moreover,
NOP2/Sun
methyltransferase
2
(NSUN2)
catalyzes
addition
transcriptionally
downregulated
by
protein
HBx,
which
suppresses
EGR1
NSUN2
promoter.
Additionally,
expression
correlates
with
type
I
IFN
host
cells,
thus,
positively
regulating
expression.
Hence,
delicate
regulation
induces
while
decreasing
levels
mRNA,
making
it
a
vital
component
life
cycle.
These
findings
provide
new
molecular
insights
into
mechanism
HBV-mediated
may
inform
development
IFN-α
based
therapies.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 8, 2024
Abstract
Liver
injury
is
a
core
pathological
process
in
the
majority
of
liver
diseases,
yet
genetic
factors
predisposing
individuals
to
its
initiation
and
progression
remain
poorly
understood.
Here
we
show
that
asialoglycoprotein
receptor
1
(ASGR1),
lectin
specifically
expressed
liver,
downregulated
patients
with
fibrosis
or
cirrhosis
male
mice
injury.
ASGR1
deficiency
exacerbates
while
overexpression
mitigates
acetaminophen-induced
acute
CCl4-induced
chronic
injuries
mice.
Mechanistically,
binds
an
endoplasmic
reticulum
stress
mediator
GP73
facilitates
lysosomal
degradation.
depletion
increases
circulating
levels
promotes
interaction
between
BIP
activate
stress,
leading
Neutralization
not
only
attenuates
deficiency-induced
but
also
improves
survival
received
lethal
dose
acetaminophen.
Collectively,
these
findings
identify
as
potential
determinant
susceptibility
propose
it
therapeutic
target
for
treatment
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(2)
Published: Jan. 10, 2024
Nuclear
import
of
the
hepatitis
B
virus
(HBV)
nucleocapsid
is
essential
for
replication
that
occurs
in
nucleus.
The
~360-angstrom
HBV
capsid
translocates
to
nuclear
pore
complex
(NPC)
as
an
intact
particle,
hijacking
human
importins
a
reaction
stimulated
by
host
kinases.
This
paper
describes
mechanisms
recognition
importins.
We
found
importin
α1
binds
localization
signal
(NLS)
at
far
end
coat
protein
Cp183
carboxyl-terminal
domain
(CTD).
NLS
exposed
surface
through
icosahedral
quasi-sixfold
vertex.
Phosphorylation
serine-155,
serine-162,
and
serine-170
promotes
CTD
compaction
but
does
not
affect
affinity
α1.
binding
30
α1/β1
augments
diameter
~620
angstroms,
close
maximum
size
trafficable
NPC.
propose
phosphorylation
favors
externalization
prompts
its
surface,
exposing